Ticker brief
TXG 10X GENOMICS INC-CLASS A
Consumer, Non-cyclical · Healthcare-Products
last close
$71.55
1 day
+2.6%
14 days
-11.3%
mkt cap
$5.0B
signals 14d
69
authors 14d
41
crowd 14d
-1.7σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 96% rich · 84 pctile own 1y | IV/HV 1.03× |
| Skew — 25Δ RR 30d | -0.093 22 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +0.44 elevated | 5-session Δ -0.02 (as of 2026-07-08) |
| OI alarm | quiet | last alarm 2026-06-05 (z=3.9) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-16 · now -0.45 (−1 bearish … +1 bullish)
Who spoke41
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @fundmyfund | B | -0.41 | 6 | +0.00 |
| @1ChartMaster | C | -2.95 | 4 | +0.54 |
| @SixSigmaCapital | B | +0.16 | 4 | -0.14 |
| @AlexsOptions | C | -1.18 | 4 | +0.01 |
| @RichardMoglen | B | +0.15 | 3 | -0.15 |
| @KeithMcCullough | A | -3.03 | 3 | +0.18 |
| @cfromhertz | B | -0.96 | 3 | +0.37 |
| @nextbigtrade | B | -1.29 | 3 | -0.03 |
| @MartyChargin | C | -0.56 | 3 | +0.25 |
| @21cshock | C | +2.21 | 2 | -0.20 |
| @ConnorJBates_ | B | -0.78 | 2 | +0.38 |
| @LogicalThesis | A | -1.21 | 2 | -0.60 |
| @cnfinancewatch | B | -1.23 | 2 | +0.42 |
| @NirAoo7 | C | -1.64 | 1 | +0.35 |
| @RESERVAdeVALOR | C | -1.11 | 1 | +0.25 |
| @TheLAPurchaser | A | +0.30 | 1 | -0.70 |
| @benitoz | B | -2.30 | 1 | +0.55 |
| @Investnews111 | C | -1.42 | 1 | +0.65 |
| @Leoskie_L | A | -1.21 | 1 | +0.35 |
| @Markadiusz45 | C | -2.22 | 1 | -0.50 |
| @SayNoToTrading | A | -0.55 | 1 | -0.40 |
| @DrStoxx | C | +0.18 | 1 | -0.30 |
| @johnscharts | C | -1.68 | 1 | -0.70 |
| @TedHZhang | B | -2.90 | 1 | -0.35 |
| @eugeniodeveze | C | -3.14 | 1 | -0.20 |
Recent signals30of 69 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @RichardMoglen | -0.45 | Says TXG's selling pressure will probably require an entirely new base. | +2.4% | tweet ↗ |
| 2026-10-15 | @TradeIdeasLLC | +0.00 | Daily swing-setup watchlist with price alerts but no concrete entry intent. | -1.2% | tweet ↗ |
| 2026-10-14 | @LogicalThesis | -0.70 | Discloses current short positions in ALAB, NET, TXG and CRWD. | -2.1% | tweet ↗ |
| 2026-10-13 | @Hedgeye | +0.80 | Promotes completed gains in five model-selected stocks over stated holding periods. | -0.3% | tweet ↗ |
| 2026-10-13 | @bugra_kurtoglu | +0.70 | Lists leading one-year US stock returns, capped to the first six named securities. | -0.3% | tweet ↗ |
| 2026-10-13 | @cnfinancewatch | +0.40 | The table reports multiple analyst price-target increases across six directly listed stocks. | -0.3% | tweet ↗ |
| 2026-10-12 | @Stockspy1 | +0.42 | Explicitly says this is not a price at which the author would buy TXG. | -4.8% | tweet ↗ |
| 2026-10-11 | @equitydd | +0.10 | Lists the first six stocks in a broad ranking of currently trending names. | -11.3% | tweet ↗ |
| 2026-10-10 | @SixSigmaCapital | -0.50 | Explicitly says the author does not like TXG. | -11.3% | tweet ↗ |
| 2026-10-10 | @1ChartMaster | +0.45 | Recaps a stop, re-entry at 8-week support and unloading most shares into Friday strength. | -11.3% | tweet ↗ |
| 2026-10-09 | @MartyChargin | +0.50 | Highlights a strong rebound in TXG. | -11.3% | tweet ↗ |
| 2026-10-09 | @Brad_E_Schulz | +0.25 | Reports intraday sector breadth and qualifying clean-energy and healthcare movers. | -11.3% | tweet ↗ |
| 2026-10-09 | @KeithMcCullough | +0.00 | Reports the current TXG trade price as $79.11 without a clear stance. | -11.3% | tweet ↗ |
| 2026-10-09 | @fundmyfund | +0.35 | Characterizes TXG as rebounding after being heavily sold three days earlier. | -11.3% | tweet ↗ |
| 2026-10-09 | @1ChartMaster | +0.50 | Highlights a strong TXG bounce. | -11.3% | tweet ↗ |
| 2026-10-09 | @cfromhertz | +0.30 | MRNA is back near its highs while the broader genomics group is acting well. | -11.3% | tweet ↗ |
| 2026-10-08 | @KeithTradeSmith | +0.75 | AI-driven genomics is presented as an early-stage secular theme with further upside after pullbacks. | -7.4% | tweet ↗ |
| 2026-10-08 | @nextbigtrade | +0.00 | Flags 10x Genomics in pre-market trading without stating the direction or magnitude. | -7.4% | tweet ↗ |
| 2026-10-07 | @KeithMcCullough | -0.15 | Declines to issue a buy signal after a 257% gain and warns that large winners correct. | -6.0% | tweet ↗ |
| 2026-10-07 | @theflynews | +0.25 | Reports 10x Genomics entered a research collaboration with Fred Hutchinson. | -6.0% | tweet ↗ |
| 2026-10-06 | @AntonLaVay | -0.50 | Biotech's crash is framed as the first sign of broader liquidation in crowded winners and weakening breadth. | -11.3% | tweet ↗ |
| 2026-10-06 | @DJ_Tao | -0.60 | Author celebrates a completed TXG short and says the company's claims triggered skepticism. | -11.3% | tweet ↗ |
| 2026-10-06 | @nextbigtrade | -0.45 | A sarcastic '8x Genomics' pun expresses a negative view of 10x Genomics. | -11.3% | tweet ↗ |
| 2026-10-06 | @ConnorJBates_ | +0.25 | The author describes rotation from extended genomics leaders into laggards and warns against late breakouts. | -11.3% | tweet ↗ |
| 2026-10-06 | @RichardMoglen | -0.35 | Identifies a key reversal bar in TXG. | -11.3% | tweet ↗ |
| 2026-10-06 | @Volume_Stocks | +0.80 | Highlights that TXG has gained more than 600% since an earlier chart call. | -11.3% | tweet ↗ |
| 2026-10-06 | @bullishchart | -0.30 | Warns late TXG buyers may absorb profit-taking beyond the measured move. | -11.3% | tweet ↗ |
| 2026-10-06 | @fundmyfund | +0.55 | Frames genomics and AI drug discovery as a momentum-backed thematic group. | -11.3% | tweet ↗ |
| 2026-10-06 | @DavidCoxRJ | -0.45 | Flags bearish reversal candlesticks across recently strong genomics names. | -11.3% | tweet ↗ |
| 2026-10-06 | @AlexsOptions | +0.00 | References TXG's move but requires unseen media to determine direction or setup. | -11.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.